Spasticity is involuntary overactivity of muscles that occurs following upper motor neuron damage to the brain or spinal cord. Upper limb spasticity is common after stroke and can cause deformity, ...

Upper limb spasticity is a painful condition caused by extremely tight muscles that can't be controlled. It's often a side effect of stroke, neurological disease or brain injury, but a new type of ...

The treatment was already approved for pediatric upper limb spasticity earlier this year. This new approval was based on data from a phase 3 trial evaluating the safety and efficacy of Botox in 381 ...

The Food and Drug Administration (FDA) has approved Botox (onabotulinumtoxinA; Allergan) for the treatment of upper limb spasticity in pediatric patients 2-17 years of age. The approval was based on ...

Many stroke patients suffer from spasticity of the arm that cause pain and impaired sensorimotor function. But there are ways of identifying such patients ahead of time so that they can obtain the ...

SL-1002 demonstrated a favorable safety profile in adult patients with limb spasticity, achieving the primary safety endpoint of this first-in-human study. Key secondary efficacy endpoints were also ...

DUBLIN, Jan. 22, 2016 /PRNewswire/ -- Allergan plc (AGN), a leading global pharmaceutical company today announced that the U.S. Food and Drug Administration (FDA) has approved BOTOX® ...

(BPT) - Spasticity is a condition in which there is an abnormal increase in muscle tone or stiffness in one or more muscles. Spasticity is usually caused by damage to nerve pathways in the brain or ...

Botulinum toxin type A was first used for the treatment of spasticity in 1989. A small uncontrolled study of treatment of upper limb spasticity after stroke reported encouraging benefits, including ...

- BOTOX® is the First and Only FDA-Approved Neurotoxin Treatment for Both Upper and Lower Limb Spasticity - DUBLIN, Jan. 22, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global ...